Hard-won! my country’s first “frozen baby” undergoes health review
Release time:
2021-11-04
Recently, Beijing Obstetrics and Gynecology Hospital welcomed a special baby. This is the first child in China to become pregnant naturally after a successful transplant of cryopreserved ovarian tissue. The 45-day re-examination results showed that all indicators of the baby were normal and everything was healthy!
Background information
Ovarian tissue cryopreservation transplantation is to remove part of the patient's ovaries and freeze them. After the patient recovers, the frozen ovarian tissue will be transplanted back into the body. In this way, the patient's fertility and normal ovarian function can be extended for 10, 20 or even 30 years.
Success!
Two-year frozen ovarian tissue returned to mother's body to give birth to healthy baby
Holding her sleeping child in her arms, Ms. Li arrived at the 13th floor of the ward building of Beijing Obstetrics and Gynecology Hospital and opened the door of Ruan Xiangyan's office. "Director, the child is very healthy during the review. Look at the examination sheet. He is 54.5 centimeters tall and weighs 4720 grams!"
Ruan Xiangyan and Ms. Li
Ms. Li is the first patient in China to have a natural pregnancy after cryopreserved ovarian tissue transplantation. Five years ago, she made the decision to undergo cryopreservation of ovarian tissue here.
In April 2016, Ms. Li was diagnosed with myelodysplastic syndrome, and bone marrow transplantation was the only cure. However, the high-dose chemotherapy before the transplant will seriously damage her ovarian function, and she may lose the chance of becoming a mother forever.
At that time, Ms. Li was only 29 years old, and the news kept her awake all night. For this situation, the most common method is to freeze eggs. However, Ms. Li, whose physical condition is already in poor condition, still has no available mature eggs after two weeks of ovulation induction injections. Inadvertently, Ms. Li learned that "the obstetrics and gynecology hospital is conducting an experiment on ovarian tissue cryopreservation."
On September 25, 2016, before chemotherapy, Ruan Xiangyan’s team from Beijing Obstetrics and Gynecology Hospital removed half of Ms. Li’s bilateral ovaries and processed them into 23 pieces of ovarian tissue as thin as cicada wings. A week later, the bone marrow transplant went smoothly.
In September 2018, Ms. Li's original disease was completely cured and she now has her own "little family". At this time, she thought of the ovarian tissue that had been frozen two years ago, so she came to Beijing Obstetrics and Gynecology Hospital to find Ruan Xiangyan.
After completing various tests, 6 pieces of Ms. Li's ovarian tissue were returned to the body. Three months later, the long-lost menstruation returned, and the menopausal symptoms slowly disappeared. On December 31 last year, she became pregnant, becoming the first patient in China to have a natural pregnancy after cryopreserved ovarian tissue transplantation.
Ruan Xiangyan processes ovarian tissue in the ovarian tissue cryopreservation bank
On August 31 this year, a new life came into this world. "The weight is 3345 grams, the height is 49 cm, the score is 10 points, and the development is very good!"
The birth of the "cryopreserved baby" is the third time that Ruan Xiangyan's team has achieved a breakthrough in the history of reproductive medicine in China, following the successful transplantation of China's first cryopreserved ovarian tissue in 2016 and the first natural pregnancy in my country in 2020.
This is a miracle of medicine and a blessing that cryopreservation brings to mankind! In the liquid nitrogen freezing tank at minus 196°C, there are opportunities for new life. At the right time, they will be "awakened" and transplanted back into their owners.
Forward
Low-temperature freezing of tissues and organs benefits human health
Ovarian tissue preservation at Shandong Yinfeng Institute of Life Sciences
At present, in my country, many medical institutions and scientific research institutes have successively carried out research and exploration on cryopreserved ovarian tissue. Shandong Yinfeng Life Sciences Research Institute is also following the trend, and has cooperated with clinical and medical institutions such as the Infertility Diagnosis and Treatment Center of Qilu Hospital of Shandong University. In cooperation with scientific research institutions, we have effectively explored the vitrification and cryopreservation of large ovarian tissues, and conducted research on the vitrification and recovery of 15 cases of human ovarian tissue. At the same time, our hospital continues to explore and establish a tissue and organ bank on the basis of stem cell preservation and recovery. Currently, it has achieved cryopreservation and recovery of skin, severed fingers/toes, valves, amniotic membrane, blood vessels, ovarian tissue, etc.
We expect that as tissue cryopreservation and transplantation technology is promoted across the country, more patients will have hope of regaining their lives in the future.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
